Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What meat are you looking for? If you are looking for a specialty cut only, marbled just right and lean, you won't pick this up maybe.
The fact that a news station runs a story isn't proof of anything. However, to release a PR with a news story in the face of a SEC Trading Suspension claiming basically that the same information of a 15 second test kit is what put you under their headlights, IS meat. It means come and test it in person or look over the shoulder of the FDA approved lab to see if it works instead of over the phone.
It also reaffirms what others have denied: i.e. that he has a test and it is being tested right now and most likely he is assured of the results because they have already thoroughly tested it in Daegu South Korea.
That's meat enough for me. I enjoy hamburger.
He's called a scammer if he puts out PRs. He's called a scammer if he doesn't reply to a SEC Trading Suspension within 24 hours.
He's called BS when signing a 550 Petition Form under oath and penalty of prosecution.
Now he fights back in the public arena to try to get out from under the rubble of the Trading Suspension and smear that puts on the company and people take it as further proof that company isn't valid.
Hardly seems objective or fair. He wouldn't put out what he has said before, under a 5 year possible SEC time frame of further action unless he had the data to back it up in my opinion. I give him credit for putting this out where enough people with power and connections might ask the question: Is this legit? Who at the SEC took action and why? I think his test works and he wants an investigation so that he can come out on top.
I tell you the guy has courage and his confidence in the product must be sky high to pass testing to release this statement in the midst of SEC action.
Seems to be proving a lot of other people's statements as false or unwarranted.
I agree that the CEO needs a better assistant for reviewing paperwork, but I believe he has a test because the test's functioning doesn't depend on him, it depends on the scientists who designed and developed it, Dr. Musho and his wife, who are clearly competent.
But there is something everyone can do to possibly help clear the water and that is to ask the Pence COVID-19 Task Force to look into whether DECN has the test kit and whether or not the SEC had verified whether or not it worked before suspending trading in the company. Because, if the SEC did not, then basically, they are the number #1 disseminator of "mis-leading information in the marketplace" concerning DECN, doing the very thing they claim to be suspending the company for since their #1 public reason was doubting the fact the company had a test kit that worked.
Ask the WH and Pence team to ask the SEC whether or not DECN's test kit works. I know, the FDA does testing, but asking them to ask the SEC for the reasons behind the Suspension will accomplish other things as well: 1. Bring the company's possible quick test before the team, 2. Find out whether or not the SEC has any reason to doubt that the test works and why, 3. Possibly lead to finding out whether the SEC was overzealous or went rogue to damage the company for the wrong reasons and help speed up answers/resolution.
For reference, use the SEC Suspension of Trading document reference No. 88735 / April 23, 2020
10 min on the WH web site to submit an email: Send msg to WH
Let's push for answers on DECN, the test and the SEC's actions.
Smells totally bogus. For one, DECN doesn't have a PCR test and secondly, they can't start testing or announcing upcoming collaboration without an approved device.
More rumors by either someone totally misinformed or deliberately trying to put more "mis-leading" info out in the marketplace to keep DECN in trouble.
Every day there's going to be a certain number of people "discovering" that the stock has moved to the grey markets and will probably sell as a result, up until there is news that the test kits have passed their testing with positive results.
At that point, I wouldn't expect much selling other than on the way up.
If for any reason DECN goes silent or the test kits fail, then it will go well below .12.
I'm in for the ride at this point.
If you have a lot of time, I suggest doing the DD research on the company. You can find the recently filed documents on OTC and click on the Disclosure tab. Read through the company's supplemental disclosure as well as their 550 Petition. Then you can go back to the SEC's Trading Suspension filing.
After you've digested what has been reported as taking place over the past 2+ months, you will have a much better idea of why some of us post what we post.
Paragraph 27 of 550 Petition:
I agree with you in that is what he meant given the context of the entire paragraph, but boy, you have to be very careful and be more specific it seems as to what you are saying so as to avoid misunderstanding.
He follows the statement with a sentence specifically stating that no one from the company has sold shares since the pandemic so it appears his statement about publicity is directly related to pumping up the stock price in order to sell shares and profit unlawfully from false statements etc.
But like others, I wish he had a more competent person reviewing all his statements and filings to avoid possible misunderstandings.
That statement certainly struck me as odd.
He may not have paid for any pump and dump type scheme, but to say he hasn't hired or contracted with anyone to promote the company seems very strange.
You're welcome. I had not seen your post while working on mine, but I agree with yours. We are both seeing the same thing, and the fact that those who have it out for KB are the ones indicating that that link "proves" misleading info and inferring that they themselves might have reported the company to the SEC are important indicators as well as to what has been going on.
Thanks. Appreciated.
Not even if the hackers supplied misleading and falsified documents to the SEC or told the SEC that the company was advertising their product as FDA approved when in fact the document "proving" such was hacked from the companies staging or advertising documents for the future and never published by the company?
Question. The filing of 550 Petition seems to be dated May 6, 2020 and was therefore most likely filed either May 6 or May 7 before the suspension ended today.
Why is the 550 Petition not showing up on otcmarkets.com or as part of any News feed that I can see under the stock symbol?
Link is to "backend" of otcmarkets website. Does that mean it is awaiting review of some kind or posting and will show up later?
Interesting article. What jumps out is that this is coordinated from home and dependent on data from insider trading, fraud detection and market manipulation to a great extent. This seems to confirm they are dependent on various computer algorithyms to trigger alerts and computer scans for information...
Interesting points from CBS release:
- First, CBS decided to release this in spite of SEC trading suspension. (not something you think they would do lightly)
- CBS report states 30-45 seconds instead of 15 seconds, which is interesting to note and may relate to SEC's having a problem with 15 seconds as well, but is not substantial difference to impact sale of product if it works
- Report repeats what last PR stated in that FDA required testing should be completed next week, so we won't have the most important news critical to whether this goes forward or not until next week
- Berman confident that internal or international testing of kits is robust enough to state that the test kits work
- Fact that CBS did this interview we believe a while back, but decided to release now and before test results come back is certainly interesting. You wouldn't think they would want to give false hope or credence to a "scam", so one would think they have had access to more info than we do, but we don't know for sure.
Certainly hope FDA testing next week confirms the test kits, then we can truly be excited.
Exactly. The image posted from Amazonaws claiming that GevViro! was FDA approved could be:
1. An image for a future PR release by DECN that was captured/hacked and acquired by someone else and posted/sent purposely to get DECN in trouble.
2. Is just an image for a future promotion
3. Is a photo-shopped or manipulated image used by a 3rd party for whatever reason (scam, malware from hits or false reporting to SEC to raise concerns...
4. Other
I have never seen that image/slide connected to DECN's own website, so it raises questions on who and how it was acquired.
If it can be traced back to the company purposely putting it out as false advertising, it would be reason for SEC to take action, but it doesn't seem to be in line with DECN's own website, the PRs or any other official declarations by the company.
Maybe a 550 Petition and hearing would reveal more on where that image came from and if it was presented to the SEC...
Company PP on GenViro!GenViro!
Several people have posted that the PP has been altered since the SEC filing and have inferred from such that DECN is fraudulent. Or maybe it was just modified according to SEC's desire to have clearer information that kit is in development and not yet for sale.
If you read the PP, it states that the result of blood prick test is expected in less than 15 seconds, now is clearly labeled as not yet for sale in US and PR and that filing for EUA has been made.
So can anyone point out what the dramatic changes have been or what might have been stated before that is not there now that carries the weight of "scam", "fraud"?
As someone else posted recently, court documents show that J&J hired and paid people to bash DECN on message boards. Who is or isn't in that line of work is hard to say.
Bottom line: we need to know the testing results. Hopefully that comes sooner rather than later and that there are no surprises. Doesn't matter too much what people say in the meantime. The testing results will drive the price accordingly.
Statement has been discussed. Depending on how you read it, it could be anywhere from 10 days to 17 days or up until May 10th.
"10 days" to finalize issues with specialty and then 7 days for actual testing.
So besides the time to test "7 days", the rest of the window is dependent not only finalizing agreement and testing protocol preparation, it is dependent on the specialty lab being able to start testing immediately.
Those who deal daily in the business world know that variables arise. We aren't photocopying a research paper here.
But yes, one would expect a statement from the company by mid May.
Interesting how one day people are saying the company is a sham because they issue too many PRs and then they say the fact that the company isn't issuing PRs is also a sign that it's a scam.
Interesting. In a prior post today your argument was that the SEC does not evaluate things on a scientific level or words thereof. Now you are making an argument that the SEC seemingly knows it doesn't work within 15 seconds.
Which is the position you would like to stick with?
thanks.
Seems that there must be nuances here, because I have followed medical device companies who passed clinical EU trials and the products are selling all over the world, but not in the US because the FDA won't accept the clinical trial data and the company has to go through US clinical trials according to FDA.
Let's everyone keep in mind that the SEC 10 Day Suspension was not based on any claim or evidence that DECN's test kits did not exist or did not work, something you would think would be stated as a major reason for suspending the company if it didn't exist, don't you think?
The SEC had a problem with DECN claiming that they had "perfected the technology" or that the test could give results in 15 seconds because the SEC had no evidence from any other company (using different methodology) that such was even possible.
The other issue was that they didn't think DECN was capable of selling their forecasted 525M test kits within 12 months. SEC did't say that they couldn't sell 100M test kits or how many should be expected. If no test kits existed, wouldn't it have been easier for the SEC to Suspend and file charges stating that the company's PRs are clearly misleading because no test kits have been developed or exist in reality.
So the SEC is "protecting" us because there are some scams out there related to COVID-19, many actually related to having channels to resell PPE and COVID-19 tests, and the SEC deems that there is misleading information in the market from DECN stating that they have perfected a technology and expect very large sales.
Quite different from claims that the test kits don't exist, don't work or that can't/won't be sold.
Let's say DECN hasn't "pefected" the technology, but the test kits do work and they only sell a disappointing 150M kits over the first year, meaning well over 1B in revenues. Anyone on this board going to complain to the SEC on that?
I don't need to find anyone. TDA lists Grey Market stocks, last sales transactions and charts of the price history like any other stock, only without current bid/ask price or Qty. I can place a limit order like any other stock and see if it fills, only I'm not planning on selling anytime soon and would only sell on news confirming the test kits either don't work or don't exist, neither of which after thorough study and research I believe to be true.
Wouldn't it be great to see a combined PR stating: "GenViro! passes FDA testing and will be submitted into the RADx competition."
Well if you have a product platform that has been tested, works and is being sold and you develop a second product based on the same underlying technology, test it thoroughly and it works, would you not expect that product to be approved also based on when you complete the FDA protocol?
Is there any reason you would not expect your product to be approved by the FDA?
That is absolutely incorrect. It is a 10 day suspension with trading resuming on May 8th per the suspension notice itself.
As has been discussed at length on this board, the 10 Day Suspension triggers other rules that put the stock on the "Grey Markets" where it will trade until other factors come into play that could put it back on OTC.
Update: The link provided for Universal Response PDF download has a description seemingly of the "at-home" screening test kits. While the website order page has a disclaimer "upon FDA approval", there is nothing in the product description describing that the product itself is in the process of development for FDA approval. While DECN was going to submit the test kit to the FDA for EUA, seems Universal is playing with fire by not having a clear disclaimer or notice that the product hasn't yet cleared FDA EUA.
Makes me nervous. Sure, seems like those at DECN and Universal have complete confidence in getting FDA approval, but in today's environment, seems like a bit more caution is warranted.
Thanks for the post as this type of information is very helpful.
Most likely the 3,000 samples tested were in Daegu, South Korea where they have stated they have tested all their products as that is where manufacturing and scientific research seems to be done.
Foreign testing data is not accepted by FDA, but knowing what the test kits have shown, KB is confident it will pass USA testing which has to be done according to FDA protocol which it what is supposed to be being done right now and completed by mid-May or before.
Another potential windfall for the company is the RADx competition announced yesterday by the NIH. RADx
Should DECN pass the Specialty Labs clinical testing in the US (Note: it is clear in their Mar 3 PR that all their products undergo clinical testing in South Korea prior to introduction to US.), then with their 2nd test strip for at home use, they should be an excellent candidate for and to possibly win the RADx competition which would radically change the whole projection of the company as the "go-to" two product COVID-19 testing company KB has stated is their goal.
If nothing else, I would expect DECN to enter their products, product designs in to the RADx competition and that alone is going to give them further exposure.
If their test strips for COVID-19 have already passed clinical testing in South Korea before being submitted to US Pre-EUA, you can understand the confidence and projections KB has had in his PRs.
I agree he might need to hire someone to review or produce those going forward, but thus far things have moved forward at a quick pace and according to what he has stated in his PRs regarding the development of the product and I expect as well as hope certainly to hear about some positive test results within the next couple of weeks. If it comes out before May 8th, it's a bonus.
Here is full statement and context of March 3rd PR:
If you haven't sold them, you still have them and if DECN succeeds in the FDA EUA approval because of testing results, you most likely become a millionaire within a short time if DECN gets a fair shake.
If the tests don't hold up to testing, then we all lose.
Please read the company's SEC filing of 3/30/20 on otcmarkets.com for Supplemental Disclosure beginning with page 15 to get a sense of what the company says it has done and going to do.
Tired of mis-information? Tired of false claims?
READ the right materials.
Here is an excerpt from DECN's SEC filing of 3/30/20 where it gives a pretty transparent accounting of why and how it decided to get into the COVID-19 testing and based on what science.
Now someone can claim it's all a lie and all fantasy, smoke and mirrors, but if YOU want to make a judgement, judge what the company states and not what others state about it: